skip to content

Roche’s Virtual Event following Angiogenesis 2021

Roche has hosted a virtual event on Tuesday, 16th February 2021.

Agenda:
WelcomeKarl Mahler, Head of Investor Relations and Roche Group Planning
Ophthalmology Strategy UpdateAtul Dandekar, Vice President and Global Franchise Head of Ophthalmology Product Strategy
Ophthalmology Pipeline UpdateChristopher Brittain, Vice President and Global Head of Ophthalmology Product Development
Faricimab in DME and nAMD – Phase III resultsNancy Holekamp, M.D., Retina Specialist and Clinical Investigator
Q&A

Webinar Replay

Investors

Past IR Events
View more Events

Downloads

Presentation

PDF

Related links

Roche’s Annual Report 2020Investors

How medicines are making an impact in the lives of patients

GovernanceAbout Roche

Our corporate governance principles focus on sustainable value creation and prescribe a culture that recognises standards of good corporate governance and policy of transparent communication.

Product Development PipelineSolutions

Discover our pipeline of Pharmaceutical and Diagnostics developments

Frequently asked questionsInvestors

We answer the Roche investors-related most frequently asked questions